Menu

Locate a Mesothelioma Cancer Center Near You

  • Information on top cancer centers and doctors
  • Find the right fit for your situation
  • Financial information to help with treatment costs
Get Connected

Several mesothelioma clinical trials are in progress but are not recruiting new patients. In these studies, the enrollment period has ended and new patients can not be added. Patients currently enrolled in these studies help doctors test the effectiveness of emerging mesothelioma treatments.


01. Ongoing Clinical Trials

Ongoing Mesothelioma Clinical Trials

Clinical trials are currently in progress to evaluate new mesothelioma treatment protocols. Ongoing clinical trials may accept new patients while testing on already enrolled patients. However, this timeframe is often short and then no new patients are admitted to the trials. Please note that the enrollment period for the following mesothelioma studies has concluded and no new participants are being recruited at this time.

The purpose of these studies is to determine both the safety and effectiveness of new mesothelioma drugs and treatment therapies. Click on a link to learn more about a study and to get updated information.

02. List of Ongoing Clinical Trials

List of Ongoing Mesothelioma Clinical Trials Not Recruiting Patients

Provided below is a list of mesothelioma clinical trials that are not recruiting or enrolling participants. Click on a link to learn more about each study.

Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors


Conditions: Carcinoma, Renal Cell, Mesothelioma

Last Updated: March 19, 2021

Status: Active, not recruiting

A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies


Conditions: Carcinoma, Merkel Cell, Carcinoma, Lung Neoplasms, Melanoma, Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms, Mesothelioma, Squamous Cell Carcinoma of Head and Neck

Last Updated: March 16, 2021

Status: Active, not recruiting

Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma


Conditions: Mesothelioma

Last Updated: March 11, 2021

Status: Active, not recruiting

Screening of Alberta Asbestos Exposed Workers for Lung Cancer and Mesothelioma


Conditions: Lung Neoplasms, Mesothelioma

Last Updated: March 4, 2021

Status: Active, not recruiting

Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: February 25, 2021

Status: Active, not recruiting

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors


Conditions: Carcinoma, Merkel Cell, Carcinoma, Carcinoma, Squamous Cell, Mesothelioma, Neuroendocrine Tumors, Nasopharyngeal Carcinoma, Lung Neoplasms, Carcinoma, Neuroendocrine

Last Updated: February 23, 2021

Status: Active, not recruiting

PembROlizuMab Immunotherapy Versus Standard Chemotherapy for Advanced prE-treated Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: February 8, 2021

Status: Active, not recruiting

A Study of LY3023414 in Participants With Advanced Cancer


Conditions: Neoplasms, Mesothelioma

Last Updated: February 3, 2021

Status: Active, not recruiting

Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: January 26, 2021

Status: Active, not recruiting

Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma


Conditions: Adenocarcinoma, Mesothelioma, Carcinoma, Ovarian Epithelial

Last Updated: January 22, 2021

Status: Active, not recruiting

Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma


Conditions: Vaccinia, Mesothelioma, Pleural Effusion, Malignant, Pleural Effusion

Last Updated: January 19, 2021

Status: Active, not recruiting

Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: January 5, 2021

Status: Active, not recruiting

A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors


Conditions: Neoplasms

Last Updated: January 2, 2021

Status: Active, not recruiting

A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549


Conditions: Carcinoma, Non-Small-Cell Lung, Melanoma, Triple Negative Breast Neoplasms, Mesothelioma, Neoplasms, Squamous Cell, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Adrenocortical Carcinoma

Last Updated: December 3, 2020

Status: Active, not recruiting

MEDI4736 Or MEDI4736 + Tremelimumab In Surgically Resectable Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: October 19, 2020

Status: Active, not recruiting

Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma.


Conditions: Mesothelioma

Last Updated: August 18, 2020

Status: Active, not recruiting

Feasibility of the LUM Imaging System for Peritoneal Surface Malignancies


Conditions: Neoplasms, Peritoneal Neoplasms

Last Updated: June 30, 2020

Status: Active, not recruiting

Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma


Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Mesothelioma

Last Updated: June 30, 2020

Status: Active, not recruiting

Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: June 10, 2020

Status: Active, not recruiting

Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: May 26, 2020

Status: Active, not recruiting

Psychosocial Needs and Exploration of Online Support for Patients With Mesothelioma


Conditions: Mesothelioma

Last Updated: May 8, 2020

Status: Active, not recruiting

Pembrolizumab in Treating Patients With Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: April 27, 2020

Status: Active, not recruiting

CheckpOiNt Blockade For Inhibition of Relapsed Mesothelioma


Conditions: Mesothelioma

Last Updated: April 20, 2020

Status: Active, not recruiting

Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: February 6, 2020

Status: Active, not recruiting

Icon for

Get Help Contacting



    Privacy policy: All information is secure and will never be released

    TRUSTe